<DOC>
	<DOCNO>NCT00175149</DOCNO>
	<brief_summary>Left ventricular hypertrophy ( LVH ) predict mortality start dialysis . Prevention LVH important . It know whether secondary hyperparathyroidism might induce LVH . In present study patient randomise 1.25 dihydroxycholecalciferol treatment study effect LVH .</brief_summary>
	<brief_title>Active Vitamin D Effect Left Ventricular Hypertrophy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Dihydroxycholecalciferols</mesh_term>
	<criteria>Chronic kidney disease ( Screatinin &gt; 150 &lt; 600 mikroM ) Secondary hyperparathyroidism ( Between 38 time upper limit PTH assay ) Stable blood pressure last 6 month ( less ( 160/95 ) Bhemoglobin &gt; 6 mmol/l EKG sinus rhythm sign Qwave infarction Expected follow 6 month Pregnancy Kidney transplantation Malignant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>CKD 3-4</keyword>
</DOC>